AC Immune SA - SHS (ACIU)

CUSIP: H00263105

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / SHS
Total 13F shares
28,964,304
Share change
-682,586
Total reported value
$85,733,267
Put/Call ratio
50%
Price per share
$2.96
Number of holders
36
Value change
-$2,967,065
Number of buys
21
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP H00263105?
CUSIP H00263105 identifies ACIU - AC Immune SA - SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AC Immune SA - SHS (ACIU) as of Q1 2024

As of 31 Mar 2024, AC Immune SA - SHS (ACIU) was held by 36 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 28,964,304 shares. The largest 10 holders included BVF INC/IL, Avidity Partners Management LP, BlackRock Inc., Redmile Group, LLC, MORGAN STANLEY, WELLS FARGO & COMPANY/MN, PLATINUM INVESTMENT MANAGEMENT LTD, RENAISSANCE TECHNOLOGIES LLC, DEUTSCHE BANK AG\, and Handelsbanken Fonder AB. This page lists 36 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.